FSH Levels by Age: What Your Result Means for IVF

A plain guide to the FSH test: what the number measures, what counts as high at your age, and what it really predicts.

An FSH of 10 or more is the number most people get worried about, and the largest study of women trying to conceive found it made no difference to their chances. In a prospective study published in JAMA, women aged 30 to 44 with a high day-3 FSH were just as likely to conceive within six months as women with a normal one: 63% against 62%. Yet the same number matters a great deal once you are in a fertility clinic, because it predicts how many eggs an IVF cycle is likely to produce, how much stimulation medication it takes, and, at the extremes, whether a cycle is worth starting.

That gap between what FSH predicts and what people assume it predicts is why this guide exists. FSH (follicle-stimulating hormone) is one of the most ordered fertility blood tests in the US, and "fsh levels" is searched about 14,800 times a month. Most of what comes back reads like a verdict on fertility. It is not. FSH is an indirect signal of how hard your brain is working to grow eggs, it swings from month to month, and the threshold that counts as "high" depends on your age, your lab and why you were tested.

This guide explains what FSH is and why it rises, the normal ranges by cycle phase, after menopause and in men, what the research shows about FSH by age, and what a high result does and does not mean, for trying naturally and for IVF. It covers how FSH compares with AMH and the antral follicle count, how to time the test, what it costs, and what to do with your number. Every figure links to the study, lab or guideline it comes from, and nothing here replaces a conversation with your own doctor.

Contents

1. What FSH is, and why it rises as eggs run low
2. Normal FSH levels by cycle phase, after menopause and in men
3. FSH levels by age
4. What a high FSH means, and what it does not
5. FSH and IVF: eggs, medication and live births
6. FSH, AMH and the antral follicle count compared
7. Low FSH: what it can mean
8. FSH in men
9. FSH and menopause
10. How to test FSH, and what it costs
11. What to do with your FSH result
12. How this guide was researched

1. What FSH is, and why it rises as eggs run low

FSH is a hormone made by the pituitary gland, a pea-sized gland at the base of the brain. In women, "FSH helps control the menstrual cycle. It triggers the growth of eggs in the ovaries and gets the eggs ready for ovulation," as the US National Library of Medicine puts it ( MedlinePlus). In men, the same hormone "helps control the amount of sperm that the testicles (testes) make." Each month, a rise in FSH at the start of the cycle recruits a group of small fluid-filled sacs in the ovary, the follicles, each holding one immature egg, and one of them usually goes on to ovulate.

The pituitary does not set FSH on its own. It listens to the ovaries. Growing follicles release two signals back to the brain, inhibin B and estradiol, and both turn FSH down. The American Society for Reproductive Medicine (ASRM) describes what happens as the supply of follicles shrinks with age: "Decreased inhibin B secretion lowers the level of central negative feedback, resulting in increased pituitary FSH secretion and in higher late-luteal and early-follicular FSH concentrations (an indirect measure)" ( ASRM Practice Committee, 2020). Put simply, fewer follicles send a weaker "stop" signal, so the brain turns the volume up.

That feedback loop explains almost everything about how to read an FSH result. Girls are born with 500,000 to 1 million eggs, and "follicular atresia and ovulation result in a slow depletion of oocyte number over time," according to the same ASRM opinion. FSH does not count those eggs. It measures the brain's response to them, one step removed. Five practical consequences follow from that one fact:

• It rises late. FSH stays in the normal range until the follicle pool is already well down, so a normal FSH does not prove a normal egg supply.
• Estradiol can hide it. An early rise in estradiol pushes FSH down, which is why clinics measure both on the same day.
• It swings month to month. Each cycle recruits a different cohort of follicles, so the brain's effort, and the FSH reading, changes.
• Very high values are telling. When the brain has to shout that loudly, the ovary really is responding weakly.
• Lowering it does not add eggs. Anything that suppresses FSH changes the signal, not the supply behind it.

Keep that list in mind through the rest of this guide, because each section is really one of those five points with numbers attached. The most common mistake is to treat FSH like a thermometer reading of fertility, when it is closer to the sound of an engine straining: useful for telling you the engine is working hard, much less useful for telling you how much fuel is left, and easily muffled. That is also why online advice about "lowering your FSH" with supplements or diets misses the point. Even if a number moved, the eggs behind it would not.

Why this matters: an FSH result is meaningful only in context: your age, the day of your cycle it was drawn, your estradiol on the same day, and why the test was ordered. How to apply this: before you react to a number, find out which cycle day it came from and whether estradiol was measured with it, and read it alongside an egg-supply test such as AMH or an antral follicle count (section 6). Our guide to AMH levels by age covers the test most clinics now lead with.

2. Normal FSH levels by cycle phase, after menopause and in men

There is no single normal FSH level, because FSH moves through the menstrual cycle, changes across life, and is measured slightly differently by different labs. Results are reported in mIU/mL or IU/L, which are the same number (1 mIU/mL equals 1 IU/L), so an FSH of 8 mIU/mL and 8 IU/L are identical. What changes from lab to lab is the reference interval printed beside your result: Cleveland Clinic notes plainly that "normal ranges for FSH levels can vary from lab to lab" ( Cleveland Clinic).

Lab reference intervals also answer a different question from the one a fertility patient is asking. A lab range describes where most healthy people of that group fall, across the whole phase of the cycle. A fertility clinic is asking something narrower: on cycle day 2, 3 or 4, is FSH low enough to suggest a normal response to stimulation? That is why a day-3 FSH of 12 can sit comfortably inside a lab's follicular range and still be flagged by a fertility clinic. The intervals below come from Mayo Clinic Laboratories' test catalog for serum FSH, read with Cleveland Clinic's ranges for comparison:

Sources: Mayo Clinic Laboratories and Cleveland Clinic.

The table makes the main point on its own: the follicular-phase range runs from about 3 to 15, so almost any early-cycle result looks "normal" on a lab report. The menopause range is left out of the chart because its upper end (157) would flatten everything else; after menopause, Mayo notes, FSH levels "are generally >40 IU/L." The mid-cycle peak is the surge that, together with LH, triggers ovulation, which is exactly why a random FSH drawn without knowing the cycle day can mislead in either direction.

The fertility thresholds that matter are much lower than the top of these ranges. ASRM's own review of the research tested FSH cut-offs between 10 and 20 IU/L on cycle days 2 to 4 for predicting a poor response to IVF stimulation, and a 2015 Chinese study of 1,287 IVF patients noted that diminished reserve has long been diagnosed "when the serum basal follicle-stimulating hormone (FSH) concentration exceeds the normal range of > 10-12 IU/L" ( Fang et al., 2015). Assays matter too: "absolute values can differ from one another," ASRM notes, even though different FSH tests correlate closely.

Why this matters: "within the normal range" on a lab report and "normal for fertility" are different statements. How to apply this: read your result against the range your own lab printed, check the cycle day, and if it was drawn on day 2 to 4, compare it with the fertility thresholds in section 4 rather than with the lab range.

3. FSH levels by age

Basal FSH rises with age, but much later and more slowly than most people expect. ASRM puts the direction plainly: "Basal serum FSH concentrations increase on day 2, 3, or 4 of the menstrual cycle with advancing reproductive age" ( ASRM, 2015). What guidelines do not publish is one table of normal FSH for each age, for the reasons in sections 1 and 2: the value swings from month to month, assays differ, and FSH only climbs steeply once the egg supply is already low. The best evidence on "FSH by age" therefore comes from large groups of women tested the same way.

The largest of those datasets comes from a community laboratory in Western Australia that analysed 32,445 women referred for hormone testing. Median FSH stayed at 5 IU/L or below up to age 35 and was 6 IU/L at 35 to 40; the median did not pass 10 IU/L until after 45. Even the 97.5th percentile, the level only 1 in 40 women exceeds, was 10 or lower up to age 30, and an FSH above 9 was already above the 97.5th percentile under 25 ( Kahapola Arachchige et al., 2012). The authors' own summary is the key sentence of this section: "Follicle-stimulating hormone is a late indicator of known reducing ovarian reserve."

That lateness is visible when you put FSH beside AMH, which tracks the egg supply directly. Over the same decade in which median AMH falls from 2.5 ng/mL at 30 to 0.5 ng/mL at 40 (see our AMH-by-age guide), a typical FSH moves by only a unit or two. An older study from Sheffield, UK, of 500 regularly cycling women aged 20 to 44 attending for infertility did find "a significant progressive increase in FSH levels as early as age 29-30 years which was continued throughout the 30s and became more marked in the early 40s" ( Ahmed Ebbiary et al., 1994), but the changes are small until the 40s. The practical consequence: an FSH that is ordinary for a 42-year-old can be a warning sign at 30.

Researchers at the Center for Human Reproduction in New York turned that into age-specific limits. In 434 IVF patients whose FSH was below 12, women whose FSH sat above the 95% confidence limit for their age "produce fewer oocytes in response to normal ovulation induction protocols compared with other women their age," with an odds ratio of 2.8 for retrieving four eggs or fewer ( Barad et al., 2007). The clinic publishes the limits it uses: a day-3 FSH below 7.0 mIU/mL under 33, below 7.9 at 33 to 37, below 8.4 at 38 to 40 and below 8.5 at 41 and over ( Center for Human Reproduction). Those are one clinic's limits on its own assay, not a national standard, and they sit well below the single cut-off of 10 that many clinics still use.

Other clinics have tested the same idea on their own patients. A university hospital in Guangzhou studied 1,287 women in a first IVF cycle, all with a day-3 FSH of 12 or less: their average FSH was 7.71 IU/L under 33, 7.97 at 33 to 37 and 8.14 at 38 to 41, nearly flat across the decade. Young women above the age cut-off still produced fewer eggs (12.55 against 14.86) and had more poor responses (6.46% against 1.42%), and across all ages the odds of a poor response were 2.7 times higher ( Fang et al., 2015). The New York group estimates that about 10% of women fall outside age-specific standards before menopause ( Gleicher et al., 2011). The differences are real but modest: most women a little above their age limit still produced a good number of eggs.

Why this matters: comparing your FSH with a single adult range, or with a friend's result at a different age, can mislead in both directions. How to apply this: read your day-3 FSH against your age: under 30, anything above about 9 to 10 is unusual and worth an AMH or antral follicle count; in the late 30s and early 40s, an FSH of 8 to 10 is common and says less on its own. Section 9 covers the much higher values that come with the years before menopause.

4. What a high FSH means, and what it does not

A high day-3 FSH is a reliable warning sign when it is very high, and a weak one when it is only a little high. ASRM summarizes the evidence in one sentence: "Elevated basal serum FSH is a specific, but not sensitive, test for DOR," meaning diminished ovarian reserve ( ASRM, 2020). Specific means that when FSH is clearly high, the ovary usually is responding poorly. Not sensitive means that many women with a low egg supply still have a normal FSH, so a normal result does not rule a problem out.

ASRM's earlier review put numbers on that trade-off. Using FSH cut-offs between 10 and 20 IU/L, a high FSH predicted a poor response to IVF stimulation with a specificity of 83% to 100%, but it caught only 10% to 80% of the women who went on to respond poorly. For predicting who would not get pregnant, it was weaker still: a sensitivity of 7% to 58% and a specificity of 43% to 100%, depending on the study and cut-off ( ASRM, 2015). Those wide ranges come from the studies themselves, which used different assays, cut-offs and definitions of a poor response.

Source: ASRM Practice Committee, Testing and interpreting measures of ovarian reserve, Table 1 ( ASRM, 2015). ASRM lists "does not predict non-pregnancy" among AMH's limitations.

The most important finding for anyone not yet in treatment comes from outside the IVF clinic. In a study from the University of North Carolina, researchers followed 750 women aged 30 to 44 with no history of infertility who had just started trying, and measured their FSH on cycle day 2, 3 or 4. The 83 women with an FSH above 10 were not less likely to conceive: 63% of them were pregnant within six cycles, against 62% of women with a normal FSH, and 82% within twelve cycles, against 75% ( Steiner et al., JAMA 2017). Low AMH told the same story. The authors concluded that their findings "do not support the use of urinary or blood follicle-stimulating hormone tests or antimüllerian hormone levels to assess natural fertility" for women like those they studied.

Why would a test that predicts IVF response fail to predict natural conception? Because natural conception needs one good egg a month, and a woman with fewer follicles still ovulates one. IVF tries to recruit many eggs at once, so a smaller pool shows up directly as fewer eggs collected. That is also why one high reading should not be over-read: ASRM notes that "a single elevated FSH value in women <40 years of age may not predict a poor response to stimulation or failure to achieve pregnancy," while "consistently elevated FSH concentrations confer a poor prognosis."

FSH speaks to quantity, not to egg quality. ASRM states that "high FSH levels have not been associated with an increased risk of aneuploidy in pregnancies resulting from IVF," and a London clinic that tested embryos found the same share with abnormal chromosomes whether FSH was high or low (50.0% against 50.2%), while age drove the difference (56.2% at 38 and over against 37.5% under 38) ( Thum et al., 2008). In a Dutch comparison, women of 40 or younger with a high FSH had more cancelled cycles than women over 41 with a normal FSH (31% against 8%), but better implantation per embryo (34% against 11%) and a higher ongoing pregnancy rate per cycle (25% against 10%) ( van Rooij et al., 2003). A young woman with a high FSH has fewer eggs, not worse ones.

Why this matters: a high FSH changes the IVF plan, not the odds of a pregnancy from trying at home. How to apply this: if you have not been trying for long and have no other reason for concern, a single high FSH is not a reason to panic or to skip trying naturally; if you are planning IVF or egg freezing, it is a reason to confirm the picture with AMH and an antral follicle count and to plan for a lower egg yield.

5. FSH and IVF: eggs, medication and live births

IVF is, at its core, a dose of FSH. The stimulation injections at the start of a cycle, such as Gonal-f and Follistim, are manufactured FSH, given in doses large enough to rescue many follicles that would otherwise wither in a natural month. Your own day-3 FSH tells the clinic how hard your brain is already pushing before any medication starts. If that push is already strong and few follicles answer it, adding more FSH recruits fewer extra follicles than it would for someone whose ovaries are still easy to stimulate.

That is why FSH predicts the number of eggs an IVF cycle produces much better than it predicts pregnancy, and why its effect shows up first as cancelled cycles and smaller retrievals. A London clinic's analysis of 2,057 patients found that higher FSH "was significantly associated with more cycle cancellation, a larger amount of gonadotrophin required to achieve follicular maturity, and a lower number of eggs collected, embryos available and embryos transferred," but not with lower fertilization rates or more miscarriages ( Abdalla and Thum, 2004). The live birth rate per cycle fell as FSH rose, and it fell much more steeply for women over 38:

Source: Abdalla and Thum, Human Reproduction 2004, one cycle per patient, 1997 to 2001.

Read the table across and then down. Across, age matters more than FSH: a woman of 38 or under with an FSH over 20 had a higher live birth rate per cycle (16.7%) than a woman over 38 with a normal FSH (12.1%). The same paper reports that younger women with an elevated FSH had a 21.2% live birth rate against 12.1% for older women with a normal one, and a 49.3% cumulative live birth rate after three cycles. The authors' conclusion is worth quoting because it is the opposite of how a high FSH is often presented: "high basal FSH is not a contraindication to IVF treatment," and "the reduction in PR and LBR is due to reduced reserve rather than poor oocyte quality."

What US data shows

The largest US analysis looked at 181,536 IVF cycles reported to the Society for Assisted Reproductive Technology (SART). The share of cycles labelled diminished ovarian reserve (DOR) rose from 19% to 26% between 2004 and 2011, yet 69% of the stimulated cycles labelled DOR did not meet the standard definition of a poor response, and live birth per DOR cycle start was 15% to 17%, or 21% to 24% for women under 40 ( Devine et al., 2015). The authors concluded that "the upward trend largely represents over-diagnosis rather than improved detection." Measured directly, an FSH of 12 or more predicted a poor response with 92.2% specificity but only 25.7% sensitivity, the same specific-but-not-sensitive pattern ASRM describes.

The combination of age and FSH is where the numbers become stark. In the same SART data, women 40 or older with an FSH of 12 or more had a live birth rate of only 6.7% per stimulated cycle. At the far end, a New York clinic that treated 291 women whose FSH had reached 20 or more reported live birth rates of 8.6% per woman and 6% per started cycle, ranging from 17.2% under 35 to 1.9% over 42 ( Kushnir et al., 2018). Even so, the authors argued these women "should not be denied access to IVF based on elevated FSH levels alone," because the younger ones still had a real chance.

A moderately raised FSH matters much less than a clearly raised one. At the University of Pennsylvania, an FSH of 10 to 11.4 "was not statistically associated with pregnancy outcome," while an FSH above 11.4 "was strongly associated with inability to achieve pregnancy after IVF," and much of that effect ran through poor response to stimulation, "which may be overcome in younger women" ( Esposito et al., 2002). In a Dutch follow-up of 96 women under 40 with a regular cycle and an FSH of at least 12.3, 63.5% went on to have a baby over a median of 3.3 years, and AMH, not FSH, was what predicted who would ( Yarde et al., 2013).

Should you wait for a month with a lower FSH?

Because FSH swings from month to month, many patients are told, or decide themselves, to retest and start IVF in a month when the number is lower. The evidence says this rarely helps. In 15,573 IVF cycles in New York, the highest FSH a woman had ever recorded predicted a cancelled cycle better than the FSH in the month of treatment, and a high FSH that returned to normal was "predicted to improve VOR counts by approximately 0.5 oocytes on average," with "no improvement in pregnancy or live birth rate" ( Gingold et al., 2015). A London clinic comparing the same 39 women in a high-FSH and a low-FSH cycle found no significant difference and advised that such women "should be offered treatment without further delay" ( Abdalla and Thum, 2006).

The swings themselves are informative. In a study of 81 women with three or more IVF attempts, those with an average FSH under 15 varied by about 2.6 units from cycle to cycle, while those averaging 15 or more varied by 7.3, and "intercycle variability in basal FSH values did not predict changes in ovarian response" ( Scott et al., 1990). A history of high readings counts even when this month's is normal: at Weill Cornell, women with a history of elevated FSH produced fewer eggs in cycles with a normal FSH, and there were "no pregnancies" among patients with three or more elevated FSH readings ( Roberts et al., 2005). Waiting has a cost of its own, because the one factor that matters even more than FSH, age, keeps moving.

What FSH means for the medication bill

The same London analysis found that higher FSH meant "a larger amount of gonadotrophin" to bring follicles to maturity, and gonadotropins are the most expensive part of an IVF prescription. Clinics set each patient's dose, so the arithmetic below is an illustration, not a protocol: it prices 10 days of Gonal-f at four daily doses, at the $42 per 75 IU cash price on TrumpRx.gov and at the $236.57 per 75 IU retail cash price in the Drugs.com price guide for a 900 IU pen.

The price per unit matters at least as much as the dose. A higher daily dose at the TrumpRx price still costs far less than a standard dose at a retail pharmacy's cash price, which is why where you fill an IVF prescription can matter as much as your FSH. We compared every posted price for Gonal-f, Menopur and the other stimulation drugs in IVF medication costs after TrumpRx, and each drug has its own page, from Gonal-f to Menopur. A full cycle usually adds Menopur, a GnRH antagonist and a trigger shot on top of the FSH.

Why this matters: in IVF, FSH predicts how many eggs you are likely to get and how much medication it may take, while age remains the stronger predictor of whether those eggs lead to a baby. How to apply this: ask your clinic what egg yield it expects from your FSH, AMH and follicle count together, and what dose it plans; budget for the medication at the price you will actually pay ( our cost calculator has the rest of the cycle), and do not delay treatment for months waiting for a better FSH reading. For the national picture, the CDC's figures for live birth per egg retrieval by age are on our IVF success rates page, and how to read IVF success rates explains what those percentages measure.

6. FSH, AMH and the antral follicle count compared

FSH was the main egg-supply test for decades, and in most clinics it no longer is. The reason follows from section 1: FSH is the brain's response to the follicles, one step removed, while AMH and the antral follicle count measure the follicles themselves. ASRM explains the difference: "Inhibin B and AMH are glycoprotein hormones produced by small ovarian follicles and are therefore direct measures of the follicular pool" ( ASRM, 2020), whereas FSH is "an indirect measure." The same opinion adds that AMH "tends to decline before FSH rises," and "for this reason, AMH has largely replaced basal FSH and E2 level testing as a biomarker of ovarian reserve."

Each test also looks at a different stage of follicle. The New York group behind the age-specific FSH limits puts it this way: "post-primordial pre-antral, small follicles are, likely, best reflected in AFCs and by AMH, while larger gonadotropin-sensitive follicles are best represented by FSH," and "AMH appears more specific than FSH in predicting oocyte yields and pregnancy chances" ( Gleicher et al., 2011). The antral follicle count (AFC) is an ultrasound count of the small follicles visible early in the cycle. A meta-analysis of 11 AFC studies and 32 FSH studies found that "the predictive performance of AFC toward poor response is significantly better than that of basal FSH," although neither predicted pregnancy well ( Hendriks et al., 2005).

Sources: ASRM Practice Committee ( 2015, Table 1, and 2020).

The European Society of Human Reproduction and Embryology (ESHRE) has now made that ranking explicit. Its 2025 guideline on ovarian stimulation recommends "either antral follicle count (AFC) or anti-Mullerian hormone (AMH)" for predicting a high or low response, and states that "age, BMI, basal FSH, inhibin B, basal oestradiol, basal progesterone, and basal LH are not recommended for the prediction of ovarian response" ( ESHRE, 2025). For pregnancy and live birth it is blunter still: none of the hormone or ultrasound markers is recommended, while "female age and BMI are predictors of pregnancy and live birth." A Taiwanese IVF study reached the same split two decades earlier: FSH and age both predicted fewer eggs, but "age, but not basal FSH, was an independent predictor of pregnancy rate" ( Chuang et al., 2003).

None of these tests is a crystal ball. A systematic review of every ovarian reserve test then in use concluded that they "have only modest-to-poor predictive properties," and that if a strict threshold is used to avoid wrongly turning couples away from IVF, only "approximately 3%" are identified as having unfavourable prospects ( Broekmans et al., 2006). An earlier meta-analysis of FSH alone was blunter: "Basal FSH should not be regarded as a useful routine test for the prediction of IVF outcome" ( Bancsi et al., 2003). FSH still earns its place in specific situations: when it is very high, when it has been high repeatedly, or when it is out of line with your age.

When FSH and AMH disagree, the usual explanations are mundane. A normal FSH with a low AMH often means FSH simply has not risen yet, since it is the later signal. A high FSH with a normal AMH can be a one-off month, a sample drawn on the wrong cycle day, or an assay quirk. ASRM's reliability ratings in the table above are the tie-breaker most clinics use, which is why the AMH result usually carries more weight. Our guide to AMH levels by age gives the median AMH at each age (from 3.3 ng/mL at 25 to 0.5 ng/mL at 40 in the 22,920-woman dataset that page uses) and explains what AMH can and cannot tell you.

Why this matters: the test that worried you may be the weakest of the three. How to apply this: if you only have an FSH result, ask for an AMH test or an antral follicle count before drawing conclusions; if you have all three, give the most weight to AMH and the follicle count, and treat FSH as a check, especially on its high side.

7. Low FSH: what it can mean

A low FSH gets far less attention than a high one, but it points somewhere quite different: usually to the brain rather than the ovaries. "Lower than normal levels of FSH in women and men are often a sign of a problem with the pituitary gland or hypothalamus," MedlinePlus explains, listing being very underweight or recent rapid weight loss, not ovulating, a pituitary or hypothalamus that is not producing normal amounts of its hormones, and pregnancy among the causes ( MedlinePlus Medical Encyclopedia). Mayo Clinic Laboratories notes that FSH and LH "are both decreased in failure of the pituitary or hypothalamus" ( Mayo Clinic Laboratories).

A common reason for missed periods with a low or low-normal FSH is functional hypothalamic amenorrhea, in which the brain turns its signal down; ASRM links it to mental health conditions including depression, anxiety and eating disorders, and to sudden, dramatic changes in body weight. ASRM's 2024 guidance on missed periods describes the pattern: estradiol "more in the menopausal range (<30 pg/mL), whereas levels of gonadotropins are in the normal to low normal range; LH levels are often disproportionately lower than FSH" ( ASRM, 2024). In the same document's breakdown of secondary amenorrhea, the hypothalamus accounts for about 35% of cases, the pituitary 17% and the ovary 40%, which is why FSH and estradiol are among the first tests ordered.

Polycystic ovary syndrome (PCOS) is often linked online to a "high LH to FSH ratio," and ASRM does note that "disproportionately elevated LH levels in relation to FSH are not uncommonly encountered" in PCOS. But the ratio is not how PCOS is diagnosed. The 2023 international PCOS guideline requires two of three features: high androgens (clinical or in the blood), irregular or absent ovulation, and polycystic ovaries on ultrasound or, now, a high AMH ( Teede et al., 2023). The guideline puts PCOS at 10% to 13% of women worldwide, so it is a common reason for irregular cycles in which FSH is normal or low.

The most ordinary cause of a low FSH is the one people forget to mention to their doctor: hormonal contraception. A systematic review found that "during treatment there is a reduction in serum concentrations of FSH, LH and oestradiol," and the antral follicle count is lower too ( D'Arpe et al., 2016). AMH is affected as well: in 27,125 women, AMH was 23.68% lower on the combined pill, 23.44% lower with an implant and 22.07% lower with a vaginal ring than in women using no hormones, while a copper IUD made no significant difference ( Hariton et al., 2021). After long-term pill use, AMH and the follicle count returned to normal within 2 months of stopping ( Landersoe et al., 2020).

Why this matters: a low FSH is usually a clue about the brain's signal, your weight, stress or contraception, not a sign of a large egg supply. How to apply this: if your FSH is low and your periods are irregular or absent, the next tests are usually estradiol, prolactin, thyroid hormone and a pregnancy test, which is the sequence ASRM recommends; if you are on hormonal contraception, tell whoever orders the test, because FSH, AMH and the follicle count will all read low until a couple of months after you stop.

8. FSH in men

In men, FSH drives sperm production, and a high FSH is one of the clearest signs that the testicles themselves are struggling. FSH "helps control the amount of sperm that the testicles (testes) make," MedlinePlus explains, and "it also affects how healthy the sperm are." The feedback loop works the same way as in women: cells in the testes release inhibin B, which "blocks FSH secretion" ( Cleveland Clinic). When sperm production falls, inhibin B falls and FSH rises.

Male reference ranges are similar to women's early-cycle ranges: 1.2 to 15.8 IU/L at Mayo Clinic Laboratories and 1.5 to 12.4 mIU/mL at Labcorp ( Labcorp). The American Urological Association and ASRM's joint guideline on male infertility warns that "normal" covers a lot of ground: "an FSH level even in the upper range of this reported 'normal' range (above approximately 7.6 mIU/mL) is indicative of an abnormality in spermatogenesis" ( AUA/ASRM guideline). Combined with a physical exam, it helps separate the two main causes of a zero sperm count: an FSH above 7.6 with testes shorter than 4.6 cm "indicate an 89% likelihood of spermatogenic dysfunction" (low production), while a lower FSH with testes longer than 4.6 cm points to a blockage with 96% likelihood.

Unlike in women, FSH in men does not need careful timing. "Although serum gonadotropin levels are variable because they are secreted in a pulsatile manner, a single measurement is usually sufficient," the guideline says, and it recommends FSH and testosterone for men with a low or absent sperm count, low libido, erectile dysfunction or small testes. An elevated FSH alongside a very low sperm count is also one of the triggers the guideline gives for genetic testing (a karyotype and a Y-chromosome microdeletion test).

One practical warning stands out because it is so common. "For the male interested in current or future fertility, clinicians should not prescribe exogenous testosterone therapy," the guideline states, and "ongoing use of anabolic steroids suppresses spermatogenesis and interferes with fertility." MedlinePlus lists the usual reasons for a high FSH in men as damage from alcohol overuse, chemotherapy or radiation, genetic conditions such as Klinefelter syndrome, hormone treatment and some pituitary tumors.

Why this matters: a man's FSH is often more decisive than a woman's, because it helps tell a blockage (often fixable) from low production. How to apply this: if a semen analysis is abnormal, ask for FSH and testosterone together; read an FSH above about 7.6 as a reason for a urology or andrology opinion, and stop any testosterone or steroid use before trying to conceive.

9. FSH and menopause

In the years before menopause, FSH stops being a fertility marker and becomes a stage marker, and an erratic one. The staging system specialists use, STRAW+10, describes the order: first AMH and the follicle count fall while cycles and FSH still look normal; then, as cycles shorten, "early follicular phase (cycle days 2-5) FSH increases and becomes more variable"; and in the early menopausal transition, cycles vary in length by 7 days or more and FSH is "elevated but variable" ( Harlow et al., STRAW+10, 2012).

The late transition is the stage defined by an FSH number. It begins with a gap of 60 days or longer between periods, and "levels greater than 25 IU/L in a random blood draw" are characteristic of it, although FSH "is sometimes elevated into the menopausal range and sometimes within the range characteristic of the earlier reproductive years." That stage lasts, on average, 1 to 3 years. After the final period, FSH keeps rising and estradiol keeps falling for about two years, and then both stabilize; Mayo Clinic Laboratories notes that postmenopausal FSH levels "are generally >40 IU/L."

The Study of Women's Health Across the Nation (SWAN) enrolled 3,302 US women aged 42 to 52 and followed them through the transition. FSH began rising about 6.1 years before the final period, accelerated about 2 years before it, and reached stable levels about 2 years after it, regardless of the age at which menopause came ( Randolph et al., SWAN, 2011). Obesity blunted the rise, and an earlier SWAN analysis found that higher body weight was linked to lower FSH and that African American women had higher FSH than white women at similar estradiol levels ( Randolph et al., 2004).

Because FSH swings so widely in these years, one FSH test cannot tell you that menopause has arrived or that pregnancy is impossible. Home urine FSH tests sold for perimenopause carry the same caveat on their own labels: myLAB Box's urine FSH test, for example, says it "does not diagnose menopause with certainty" ( myLAB Box). STRAW+10 counts perimenopause as lasting until 12 months after the final menstrual period, a reminder that the calendar, not one blood test, is what settles it.

Why this matters: an FSH in the 20s or 30s in your mid-40s usually means the transition is under way, not that it is over. How to apply this: if you are 40 or older, have irregular cycles and want to know where you are, track your cycle lengths alongside any FSH result; if you want to conceive, the egg-supply tests in section 6 and a fertility consultation will tell you more than a menopause test, and if you do not want a pregnancy, ask your doctor before stopping contraception.

10. How to test FSH, and what it costs

For a woman with regular periods, an FSH test is only interpretable if it is drawn early in the cycle and read with estradiol. ASRM's opinion describes basal FSH as measured on "day 2, 3, or 4 of the menstrual cycle," the days when FSH is at its baseline before a dominant follicle takes over ( ASRM, 2020). A test drawn mid-cycle can catch the ovulation surge and look alarming, and one drawn in the luteal phase can look reassuringly low; neither tells you about egg supply.

Estradiol on the same sample is not optional. "An early rise in serum E2 concentrations is a classic characteristic of reproductive aging and can lower an otherwise elevated basal FSH level into the normal range," ASRM explains, and "when the basal FSH concentration is normal but the E2 level is elevated (>60-80 pg/mL), this may indicate ovarian dysfunction attributable to DOR." A normal FSH next to a high day-3 estradiol is therefore not fully reassuring. Three practical points round out the preparation. Hormonal contraception lowers FSH (section 7), so mention it to whoever orders the test. Labcorp advises that "patients should be cautioned to stop biotin consumption at least 72 hours prior to the collection of a sample" ( Labcorp), worth knowing because biotin is sold widely as a hair and nail supplement. And if your periods have stopped, a random FSH with estradiol is the standard first test, per ASRM's amenorrhea guidance.

Some older tests are no longer worth paying for. The clomiphene citrate challenge test, which measured FSH again after a course of clomiphene, is not better than a basal test, ASRM concludes: "this test should be abandoned." For men, timing barely matters, because "a single measurement is usually sufficient" (section 8). For everyone, one reading is a snapshot: if a result surprises you, the useful next step is usually an AMH test or a follicle count, not a second FSH a month later.

What an FSH test costs without insurance

Several companies sell FSH tests directly online, with a physician's order bundled into the price, and you have the blood drawn at a lab's patient service center. Prices below were read on each seller's own page on October 5, 2026; each includes what that page says about fees.

The single-test prices cluster around $50 to $60, against the $18.58 Medicare pays a lab for the same FSH test (plus $9.34 for the blood draw) under its 2026 fee schedule ( CMS). The most useful purchase for most people, though, is a panel that includes AMH, FSH and estradiol together, because it answers the questions in sections 4 and 6 in one blood draw. Direct-to-consumer labs charge about $219 to $225 for that, and some fertility clinics charge less for the whole first workup: RSC Bay Area offers AMH, FSH and estradiol with a written report and a phone consultation with a fertility specialist for $99, not billable to insurance ( RSC Bay Area), and the Advanced Fertility Center of Chicago charges $100 for day-3 FSH, estradiol, AMH and an ultrasound follicle count, or $150 for a couple with a semen analysis ( Advanced Fertility Center of Chicago).

Home finger-prick kits that include FSH are also widely sold. They mail a few drops of blood to a lab and return results online, and they vary a lot in what else they measure:

A home kit is convenient, but it carries the same timing rules as a lab test, and only some kits include AMH, the more useful number. A kit that measures FSH without estradiol or AMH answers the least useful version of the question; Ro's kit, for example, drops FSH from the panel for anyone on hormonal birth control. Our at-home fertility tests page compares hormone kits side by side.

Urine FSH tests

A separate class of home tests measures FSH in urine, either as a yes-or-no strip or as a number read by an app or monitor. They are cheap, but they answer a narrower question than a blood test:

The makers are careful about what these show. Mira's monitor page states that it is "not intended to diagnose, screen for, or indicate ovarian function, egg supply, or any medical conditions" ( Mira), and Clearblue says its Menopause Stage Indicator, a urine FSH test, "will be discontinued," and its app "will no longer be supported starting September 01 2026" ( Clearblue). Insurers draw the same line: Aetna's policy states that it "considers urinary FSH testing to be experimental, investigational, or unproven," and that "serum, not urinary, FSH is the standard of care for determination of menopausal status" ( Aetna, CPB 0327). A urine strip can tell you FSH is very high; it cannot stand in for a day-3 blood test read with estradiol.

FSH and your insurance

Many insurers cover FSH testing when it is part of an infertility evaluation, and some also use the result to decide what they will pay for later. UnitedHealthcare's 2026 infertility policy lists follicle-stimulating hormone among the hormone tests that are "proven and medically necessary for diagnosing or treating Infertility," while noting that "certain plans do not cover Infertility services" ( UnitedHealthcare). Aetna's policy goes further and ties IVF coverage to the number: "For women who are less than 40 years of age, the day 3 FSH must be less than 19 mIU/mL in their most recent laboratory test to use their own eggs," and for women 40 and older, the unmedicated day-3 FSH "must be less than 19 mIU/mL in all prior tests." If your plan works this way, one high reading can matter for coverage even when it says little medically, so it is worth knowing your plan's rule before you test.

Why this matters: a badly timed FSH test can create weeks of needless worry, or false reassurance. How to apply this: book the draw for cycle day 2, 3 or 4, skip biotin for three days, make sure estradiol (and ideally AMH) is on the same order, and if you are paying yourself, compare a direct-to-consumer panel with your clinic's self-pay price.

11. What to do with your FSH result

What an FSH result should change depends far more on your situation than on the number itself. The research in this guide points to a simple rule: FSH says something useful about how an IVF or egg freezing cycle is likely to go, and very little about whether you can conceive at home. ASRM's 2020 opinion puts it in one line: markers of ovarian reserve "should not be used as a fertility test for women who are not infertile or who have untested fertility," and they "should not be the sole criteria used to deny patient access to assisted reproductive technologies." The CDC defines infertility as "not being able to get pregnant (conceive) after 1 year (or longer) of unprotected sex," and notes that "some providers evaluate and treat women aged 35 years or older after 6 months" ( CDC).

With that frame, the same FSH of 11 means different things to different people. The table below sets out the common situations, what the evidence says FSH tells you in each, and the next step that evidence supports. It is a starting point for a conversation with a doctor, not a substitute for one.

Two of those rows deserve more than a table line. For egg freezing, ASRM is explicit that ovarian reserve markers "should not be used to promote planned oocyte cryopreservation," and that "decisions regarding oocyte cryopreservation should be based on a woman's reproductive plans and age," because "age is a much stronger predictor of reproductive success than is ovarian reserve." The tests still help you plan once you have decided, because they predict how many eggs a single cycle is likely to collect; what clinics charge for a cycle is in our census of egg freezing prices and the egg freezing guide.

For a very high FSH, the honest numbers are the ones from section 5: live birth rates of 8.6% per woman for FSH of 20 or more in one New York clinic, from 17.2% under 35 to 1.9% over 42. Many people in that position consider donor eggs, whose success rates do not fall with the recipient's age the way own-egg rates do; our donor egg IVF guide compares cost and success. Others try one or more own-egg cycles first, which the research supports for younger women. Either choice is reasonable; what matters is making it with real odds rather than with the number alone.

When you see a doctor about an FSH result, these questions get you the most information in a single visit:

• "What cycle day was this drawn, and what was estradiol?" Both change what the FSH means.
• "What do my AMH and antral follicle count show?" They are the more reliable egg-supply tests.
• "What egg yield do you expect per cycle?" It turns the numbers into a plan.
• "What dose and protocol would you use, and what will the medication cost?" Our medication cost comparison helps check the answer.
• "What are my realistic odds per cycle at my age?" Age remains the strongest predictor.

The answers to those questions matter more than the FSH value itself, because they combine it with everything else a clinic knows about you. If the consultation leads to IVF, our IVF cost guide and cost breakdown show what a full cycle costs beyond the medications, paying for IVF covers grants, loans and insurance, and how to read IVF success rates explains the clinic figures you will be shown.

12. How this guide was researched

Every number in this guide was read on its original source on October 4 or 5, 2026: the professional guidance from ASRM, ESHRE and the American Urological Association, peer-reviewed studies through their PubMed and PubMed Central records, lab reference pages from Mayo Clinic Laboratories, Labcorp and MedlinePlus, and test prices on each seller's own page. Where a study used an older assay standard, a different population or a single clinic's patients, the text says so, and where sources disagree (as the lab reference ranges do), both are shown. We do not average figures from different studies or invent cut-offs a source does not state.

IVFcost.co is built and run on Founden, which describes itself as an engine for autonomous software; the people behind IVFcost.co also run Founden, so take that as a note about our own tools rather than a recommendation. The site's medication prices, clinic data and research articles, including our census of clinic IVF prices and the list of the lowest posted IVF prices, follow the same rule as this guide: each figure links to the page it was read on, and the date is beside it.

The bottom line

FSH is the brain's effort to grow eggs, not a count of them. That single idea explains why a high FSH matters most when it is very high, repeatedly high or high for your age; why it predicts the number of eggs in an IVF cycle far better than it predicts a pregnancy; why it can be falsely reassuring when estradiol is high; and why lowering the number does nothing for the egg supply behind it. For women trying to conceive at home without a fertility problem, the best study available found that a high FSH made no difference to their chances at all.

If you have one FSH result in front of you, the most useful next steps are to check the cycle day and estradiol, add an AMH test or an antral follicle count, and read all of it against your age and your plans. If you are heading into IVF or egg freezing, FSH is one input into how many eggs a cycle is likely to yield and what the medication will cost, and age remains the stronger guide to the odds of a baby. Used that way, FSH is a helpful number. Read on its own, it is mostly a source of worry.

This guide reflects research, guidelines and prices as of October 5, 2026. Lab ranges vary, prices change, and nothing here is medical advice: talk to your own doctor about your results.